Moderna rockets as vaccine offers 'new paradigm ' in cancer treatment
"It's a tremendous step forward in immunotherapy"
Company
Moderna Inc
MRNA:[TICKER]
Moderna Inc is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
102 stories · page 4 of 6
Moderna Covid booster provides room for encouragement rather than complacency
The US drug developer's largely positive data mirrored similar findings released recently by Pfizer
Moderna revenue falls on lower demand for Covid jabs
Fewer people opting for covid jabs has led to decreased revenue for Moderna
Moderna and Merck ink US$250mln deal to develop world's first cancer vaccine
The US firm exercised and option that will allow to help develop and commercialise the new treatment
Moderna to open new vaccine factory in the UK
The £1bn deal will see the vaccine manufacturer collaborate with the UK government to build a manufacturing facility for messenger RNA vaccines for COVID and flu
Covid-19 cases rise in UK for first time in months
The risk of re-infection was around eight times higher for Omicron variants of Covid-19, compared to the Delta variant
Moderna conducting monkeypox vaccine trials, report
Monkeypox is common in parts of Africa, but very rarely seen elsewhere
Moderna CFO Jorge Gomez exits after just one day in the role
Though Gomez left Moderna after just one day in office, he will still receive his full US$700,000 salary for one year
Moderna expects vaccine sales to increase in the back half of 2022 with fall-winter booster in development
Sales of the Moderna vaccine were $5.9 billion in the first quarter, and the firm projects $21 billion total in 2022
Moderna bucks market slump as it ups forecast for Covid-19 jab revenues
Moderna's fortunes have been transformed by its Covid jab
Moderna in talks with UK government over vaccine research and manufacturing hub
Moderna, which sold 510mln doses of its COVID-19 vaccine in the final nine months of last year, has been long searching for overseas investments with plans in Africa, Canada, and Australia revealed in 2021
Archive
US stocks end sharply lower as Omicron fears rattle markets
At the close, the Dow fell 433 points to 34,932, while the S&P 500 eased 53 points at 4,568 and the tech-heavy Nasdaq slipped 189 points to 14,981
US stocks tank as Omicron concerns, Powell comments spook investors
The new COVID-19 variant, first detected in South Africa, has now been found in more than a dozen countries, causing many nations to restrict travel
Moderna boss predicts existing COVID-19 vaccines will be less effective against Omicron variant
Existing vaccines may need to be modified, which could take months, Stéphane Bancel told the FT
Omicron: All UK adults to get Pfizer or Moderna booster
Shares in Moderna jumped 10% today while Pfizer inched higher
Moderna tumbles after cut to Covid-19 vaccine sales forecast
Bottling capacity is proving a problem said the US pharma
US FDA advisers back Moderna COVID-19 vaccine booster for over-65s and high-risk people
Moderna is seeking authorisation for a 50 micrograms dose for the vaccine booster, which is half of its regular dose
Moderna to supply new batch of Covid vaccine to low-income countries
Prices for the latest order would be at its lowest tier, said the drug group's statement.
Moderna boss predicts pandemic will end within a year
Even those who are not vaccinated will develop natural immunity